About MiT family translocation renal cell carcinoma
MiT family translocation renal cell carcinoma is a rare disease catalogued by Orphanet (ORPHA:319308). It is associated with the PRCC, TFE3, ASPSCR1 genes. Search below for active recruiting clinical trials from ClinicalTrials.gov, or visit the Orphanet expert page for specialist centres, natural history studies, and patient registries.
Clinical Trial Eligibility Tips
What to know before applying to MiT family translocation renal cell carcinoma trials.
Search ClinicalTrials.gov for "MiT family translocation renal cell carcinoma" or filter by Orphanet code ORPHA:319308 to find disease-specific studies.
Ask your specialist to refer you to a Centre of Expertise — Orphanet lists all accredited centres for this condition worldwide.
Natural history studies and patient registries often enrol before drug trials open — contact the Orphanet patient community first.
Patient Resources
Find recruiting MiT family translocation renal cell carcinoma trials
Search 500,000+ studies from ClinicalTrials.gov, filtered for MiT family translocation renal cell carcinoma. Updated daily.